📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam et al. (2018)

First Author: Tsuchida Y

Attributed to: Maximising Therapeutic Utility for Rheumatoid Arthritis using genetic and genomic tissue responses to stratify medicines. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.40652

PubMed Identifier: 29938925

Publication URI: http://europepmc.org/abstract/MED/29938925

Type: Journal Article/Review

Volume: 70

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 10

ISSN: 2326-5191